肾脏与心脏的交互对话:细胞外囊泡的桥梁作用
慢性肾脏病(CKD)患者心血管疾病(CVD)风险显著增加,传统危险因素之外,炎症、氧化应激、矿物质紊乱和尿毒症毒素蓄积进一步加剧心血管脆弱性。本综述总结CKD中循环细胞外囊泡(EVs)的数量和分子货物改变,通过传递蛋白质和microRNA等生物活性分子促进内皮功能障碍、血管钙化、炎症、血栓形成和心脏重构,并探讨其作为CVD生物标志物和治疗靶点的潜力。
要点
- CKD中循环EVs数量和货物改变,反映代谢和炎症微环境。
- EVs通过传递蛋白质和microRNA促进内皮功能障碍、血管钙化等。
- EVs有潜力作为CKD相关CVD的生物标志物和治疗靶点。
核心结论
- EVs是连接肾功能障碍与心血管病理的关键介质,兼具生物标志物和治疗靶点潜力。
研究设计与样本
- 综述,总结CKD中EVs介导肾-心交互的机制、生物标志物价值及治疗前景。
主要发现
- CKD中循环EVs的丰度和分子货物发生改变,反映代谢和炎症状态。
- EVs通过传递蛋白质和microRNA等生物活性分子,促进内皮功能障碍、血管钙化、炎症、血栓形成和心脏重构。
- 临床前研究显示干细胞来源和工程化EVs可促进心脏修复和调节病理信号。
临床怎么用
- EVs有望用于CKD患者CVD的早期检测和风险分层。
- EVs作为治疗靶点仍需标准化、安全性验证和精心设计的人体试验。
局限性
- 临床转化需 rigorous 标准化、安全性验证和精心设计的人体试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) is a major public health concern, closely linked to an increased risk of cardiovascular disease (CVD), which remains the leading cause of morbidity and mortality in this population. While traditional risk factors such as hypertension and diabetes are prevalent in CKD, disease-specific mechanisms-including chronic inflammation, oxidative stress, mineral disturbances and the accumulation of uraemic toxins-further amplify cardiovascular vulnerability. In CKD, both the abundance and molecular cargo of circulating extracellular vesicles (EVs) are altered, reflecting the underlying metabolic and inflammatory milieu. These EVs propagate endothelial dysfunction, vascular calcification, inflammation, thrombosis and cardiac remodelling by transferring bioactive molecules such as proteins and microRNAs to target cells. Emerging evidence suggests that EVs not only serve as biomarkers for early detection and risk stratification of CVD in CKD but may also represent novel therapeutic targets. Preclinical studies demonstrate the potential of stem cell-derived and engineered EVs to promote cardiac repair and modulate pathological signalling. However, translation into clinical practice requires rigorous standardization, safety validation and well-designed human trials. This review synthesizes current knowledge on the mechanisms by which EVs bridge renal dysfunction and cardiovascular pathology, discusses their utility as biomarkers and outlines a research agenda for harnessing their therapeutic potential in CKD-associated CVD.
引用
- Zoccali C, Valdivielso JM, Vogt L, et al. Kidney-heart crosstalk: the extracellular vesicles connection. Nephrol Dial Transplant. 2026. PMID: 41661143. doi:10.1093/ndt/gfag022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。